| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/05/2002 | CN1352636A Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 06/05/2002 | CN1352568A Water soluble compositions for bioactive lipophilic compounds |
| 06/05/2002 | CN1352563A Use of phyllanthus for targeted stimulation of the immune system |
| 06/05/2002 | CN1352554A IL-8 receptor antagaonists |
| 06/05/2002 | CN1352551A Preparations for the application of anti-inflammatory agents |
| 06/05/2002 | CN1352545A 吲哚衍生物 Indole derivatives |
| 06/05/2002 | CN1351884A Medicine for treating hepatitis B |
| 06/05/2002 | CN1351876A Chinese medicine external use lotion for treating skin diseases and its preparing method |
| 06/05/2002 | CN1351871A Compound chlorhexidine cream and its prepairng method |
| 06/04/2002 | US6399781 A key intermediate in the production of nevirapine, starting by reacting acetylacetaldehyde dimethyl acetal with malononitrile, in the presence of an ammonium salt catalyst |
| 06/04/2002 | US6399773 Autoimmune disease; transplanting organs |
| 06/04/2002 | US6399771 Cyclic imines as pesticides |
| 06/04/2002 | US6399657 Antiinflammatory agents |
| 06/04/2002 | US6399656 Using a benzopyran-3-carboxamide compound |
| 06/04/2002 | US6399653 Ring fused dihydropyrans, process for preparation and use thereof |
| 06/04/2002 | US6399642 Tris benzimidazoles; fungicides, anticarcinogenic agents, enzyme inhibitor |
| 06/04/2002 | US6399636 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease (copd), eosinophilic granuloma, psoriasis and septic shock, ulcerative colitis, crohn's disease, reperfusion injury of the myocardium and brain |
| 06/04/2002 | US6399627 Anticoagulants; prothrominase, serine protease inhibitor; acrylamide derivatives |
| 06/04/2002 | US6399626 Useful in inducing immunosuppression and in treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, vascular disease |
| 06/04/2002 | US6399619 Prevention and treatment of aids and viral infection by hiv |
| 06/04/2002 | US6399603 Therapeutic heterocycles |
| 06/04/2002 | US6399597 1,8-naphthosultamylmethyl carbapenem antibacterial compounds, compositions containing such compounds and methods treatment |
| 06/04/2002 | US6399589 Viricides; antitumor agents |
| 06/04/2002 | US6399582 Ketolide antibacterials |
| 06/04/2002 | US6399576 Administering dosage of batroxobin |
| 06/04/2002 | US6399571 Polypeptides |
| 06/04/2002 | US6399570 Mutant; active materials; proteolytic digestion of lactoferrin |
| 06/04/2002 | US6399567 Cyclic hexapeptides having antibiotic activity |
| 06/04/2002 | US6399370 Compositions and methods for use of defensin |
| 06/04/2002 | US6399312 Myostatin gene promoter and inhibition of activation thereof |
| 06/04/2002 | US6399294 Probes; primers; immunogens; for diagnosis of human immunodeficiency virus infections |
| 06/04/2002 | US6399139 Controlling material handling |
| 06/04/2002 | US6399095 Aloe leaves, freeze drying and vacuum drying |
| 06/04/2002 | US6399087 Dissolving in a solvent, emulsification with water and surfactant |
| 06/04/2002 | US6399079 Spill resistant pharmaceutical compositions in semi-solid form |
| 06/04/2002 | US6399076 Acellular pertussis vaccines and methods of preparation thereof |
| 06/04/2002 | US6399074 Live attenuated salmonella vaccines to control avian pathogens |
| 06/04/2002 | US6399067 Methods and compositions for impairing multiplication of HIV-1 |
| 06/04/2002 | US6399066 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 06/04/2002 | CA2361950A1 Antibiotics g 23077, pharmaceutically acceptable salts and compositions, and use thereof |
| 06/04/2002 | CA2239352C Injectable quinolone formulations |
| 05/30/2002 | WO2002042484A2 Method for producing pectin hydrolysis products |
| 05/30/2002 | WO2002042444A2 Fungal gene cluster associated with pathogenesis |
| 05/30/2002 | WO2002042443A2 Use of modulators of eukaryotic signal transduction pathways for the treatment of helicobacter infections |
| 05/30/2002 | WO2002042429A2 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
| 05/30/2002 | WO2002042412A2 Protease inhibitors and their pharmaceutical uses |
| 05/30/2002 | WO2002042335A1 Polysaccharide compound having immune stimulating activity |
| 05/30/2002 | WO2002042333A1 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding |
| 05/30/2002 | WO2002042332A2 Truncated cd200 |
| 05/30/2002 | WO2002042330A2 Cystoskeleton-associated proteins |
| 05/30/2002 | WO2002042328A2 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon |
| 05/30/2002 | WO2002042319A2 2-substituted estrogens as antiangiogenic agents |
| 05/30/2002 | WO2002042316A2 Pna analogues |
| 05/30/2002 | WO2002042315A2 Macrolide solvates |
| 05/30/2002 | WO2002042312A1 Novel carbapenem derivatives |
| 05/30/2002 | WO2002042306A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 05/30/2002 | WO2002042301A1 Novel pyridine-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042297A1 Piperidine compounds and medicinal use thereof |
| 05/30/2002 | WO2002042296A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 05/30/2002 | WO2002042292A2 Indol derivative and their use as inhibitors of p38 kinase |
| 05/30/2002 | WO2002042279A1 Imidazolone derivatives for the treatment of viral diseases |
| 05/30/2002 | WO2002042278A2 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | WO2002042277A1 Novel compounds for use as hiv protease inhibitors |
| 05/30/2002 | WO2002042273A2 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | WO2002042269A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/30/2002 | WO2002042266A2 Process for the production of ceftifur sodium salt |
| 05/30/2002 | WO2002041912A1 Drugs and foods improving the quality of life and process for producing the same |
| 05/30/2002 | WO2002041910A2 Methods and compositions for the treatment of diseases of the eye |
| 05/30/2002 | WO2002041908A1 Process for preparing aqueous extracts of plants and extracts so obtained |
| 05/30/2002 | WO2002041904A1 Method for treating hiv |
| 05/30/2002 | WO2002041903A1 The composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator |
| 05/30/2002 | WO2002041893A1 Therapy for herpes neurological viral conditions utilizing 1,4-dihydropyridine calcium channel blockers |
| 05/30/2002 | WO2002041891A2 Hiv treatment with benzimidazoles |
| 05/30/2002 | WO2002041886A1 Ydroxamic acid or n-formyl hydroxylamine derivatives as inhibitors of bakterial polypeptide deformylase for treating microbial infections |
| 05/30/2002 | WO2002041843A2 Antiinflammation agents |
| 05/30/2002 | WO2002028440B1 Methods and compositions for modulating t cell activation and uses thereof |
| 05/30/2002 | WO2002028423A8 Stabilisation of plasmid inheritance in bacteria by preventing multimerisation |
| 05/30/2002 | WO2002026242A3 Inhibition of systemic infections in humans and vertebrates by dietary fibers |
| 05/30/2002 | WO2002022782A3 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 05/30/2002 | WO2002022648A3 Compositions and methods for inducing specific cytolytic t cell responses |
| 05/30/2002 | WO2002022599A3 Chemokine receptor binding heterocyclic compounds |
| 05/30/2002 | WO2002020736A9 Proteases |
| 05/30/2002 | WO2002020538A3 Stavudine polymorphic form 1 process |
| 05/30/2002 | WO2002018581A9 G-protein coupled receptors |
| 05/30/2002 | WO2002018438A9 Modified proteins, isolated novel peptides, and uses thereof |
| 05/30/2002 | WO2002009643A3 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 05/30/2002 | WO2002004444A3 Heterocycle carboxamides as antiviral agents |
| 05/30/2002 | WO2002004034A3 Polymer-bound metal-containing compositions |
| 05/30/2002 | WO2002000663A3 Polycyclic xanthones as antibiotics |
| 05/30/2002 | WO2001098270A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 05/30/2002 | WO2001097778A3 Amphotericin b structured emulsion |
| 05/30/2002 | WO2001092333A3 Use of adnf for enhancing learning and memory |
| 05/30/2002 | WO2001091737A3 Methods for treating hepatitis delta virus infection with beta-l-2' deoxy-nucleosides |
| 05/30/2002 | WO2001089495A3 Antibiotic compositions containing quinolone derivatives for treatment of the eye, ear and nose |
| 05/30/2002 | WO2001087330A3 Compositions and methods for achieving immune suppression |
| 05/30/2002 | WO2001085709A3 New compounds having anticancer activity: process for their preparation and pharmaceutical compositions containing them |
| 05/30/2002 | WO2001085149A3 Felbamate derived compounds |
| 05/30/2002 | WO2001083561A3 Anthrax-specific antigen, vaccines comprising said antigen, anthrax-specific antibodies, and their uses |
| 05/30/2002 | WO2001083520A3 Polyacid glycopeptide derivatives |
| 05/30/2002 | WO2001078700A3 Compositions for use in modulating immune system function comprising at least one retrinoid and at least one cytokine |